maleimide has been researched along with Malignant Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Daniels, G; Esener, S; Futalan, D; Larsson, M; Messmer, B; Messmer, D; Saenz, R; Tor, Y | 1 |
1 other study(ies) available for maleimide and Malignant Melanoma
Article | Year |
---|---|
Activity of the HMGB1-derived immunostimulatory peptide Hp91 resides in the helical C-terminal portion and is enhanced by dimerization.
Topics: Adjuvants, Immunologic; Amino Acid Sequence; Animals; Cell Line, Tumor; Dendritic Cells; Female; HMGB1 Protein; Humans; Immunotherapy, Adoptive; Leukocytes, Mononuclear; Lymphocyte Activation; Maleimides; Melanoma; Mice; Mice, Inbred C57BL; Peptide Fragments; Protein Binding; Protein Multimerization; Structure-Activity Relationship; Th1 Cells | 2014 |